Journal of Pain Research (Jul 2021)
Beta-Endorphin as a Biomarker in the Treatment of Chronic Pain with Non-Invasive Brain Stimulation: A Systematic Scoping Review
Abstract
Erickson Bonifácio de Assis, Carolina Dias de Carvalho, Clarice Martins, Suellen Andrade Neuroscience and Aging Laboratory, Federal University of Paraíba, João Pessoa, PB, BrazilCorrespondence: Suellen AndradeNeuroscience and Aging Laboratory, Federal University of Paraíba, João Pessoa, 58051-900, BrazilTel +55 83 3216-713Email [email protected]: A scoping review to synthesize evidence and assess articles describing the use of beta-endorphins as a pain biomarker in chronic pain patients treated with non-invasive brain stimulation techniques was systematically performed with respect to the study quality, the technique employed and the results. Independent reviewers determined if the article met the study criteria at each stage for it to be included. Content analysis was applied and summarized. The results are described in a narrative form grouped by pain condition, type of intervention, stimulation protocol, outcome measures and main results. A total of 67 of 73 references were excluded, and 6 identified studies met the inclusion criteria. The study design, sample size, stimulation type, session protocol and the main findings of each study were extracted. The studies in this scoping review ranged from unsatisfactory to good based on the adopted criteria, with no study achieving an excellent rating. There is limited evidence on the dosage of beta-endorphin in chronic pain conditions during treatment with NIBS. Based on this literature, evidence suggests that BE may not only be useful for acute and persistent pain, but also for a variety of chronic pain states in which opioids are not effective.Keywords: chronic pain, endorphin, electric stimulation, review
